Synthesis and Mechanism of p53-MDM2 Inhibitors with Heterocyclic Structures: A Focused Review

被引:0
|
作者
Ji, Li-Tao [1 ]
Zhang, Wenjing [1 ]
Zhang, Yi [1 ]
Zhao, Su [1 ]
Long, Hai-Tao [1 ]
Qin, Li-Qing [1 ]
Tian, Jia-Cheng [1 ]
Li, Hong-Zhang [1 ]
Zhu, Dan-Xue [1 ]
Zhou, Yan [1 ]
Lu, Yi-Duo [1 ]
Wang, Zhen-Chao [1 ,2 ,3 ]
Li, Cheng-Peng [1 ,2 ,3 ]
机构
[1] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China
[2] Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550025, Peoples R China
[3] Guizhou Univ, Guizhou Engn Lab Synthet Drugs, Guiyang 550025, Peoples R China
来源
CHEMISTRYSELECT | 2023年 / 8卷 / 45期
关键词
Small molecule; heterocyclic compounds; p53-MDM2; cancer; synthesis method; SMALL-MOLECULE INHIBITORS; PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED DESIGN; BIOLOGICAL EVALUATION; MDM2; INHIBITORS; SPIRO-OXINDOLES; CLINICAL-TRIALS; P53; PATHWAY; POTENT; DISCOVERY;
D O I
10.1002/slct.202302240
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
P53 gene mutation is one of the important causes in tumors. p53-MDM2 (murine double minute 2) inhibitors can interrupt p53-dependent gene transcription activity, and inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this article, we focused on the synthesis methods about nutlins and other p53 small molecule inhibitors, in order to find potential new structure for novel p53 small molecule inhibitor synthesizing. Mutation of the p53 gene is among the most important causes of tumors. Inhibitors of p53-MDM2 can impede p53-dependent gene transcription, inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this review we discuss the synthesis of nutlins and other small-molecule p53 inhibitors, with an aim to inspire new structures and methods for the synthesis of future small-molecule p53 inhibitors.+image
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Small molecule inhibitors of the p53-MDM2
    Hu, Chun-Qi
    Hu, Yong-Zhou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1720 - 1730
  • [2] p53-Mdm2 inhibitors: patent review (2009-2010)
    Kamal, Ahmed
    Mohammed, Ameruddin Azhar
    Shaik, Thokhir B.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (02) : 95 - 105
  • [3] Artificial Macrocycles as Potent p53-MDM2 Inhibitors
    Estrada-Ortiz, Natalia
    Neochoritis, Constantinos G.
    Twarda-Clapa, Aleksandra
    Musielak, Bogdan
    Holak, Tad A.
    Domling, Alexander
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (10): : 1025 - 1030
  • [4] Synthesis and evaluation of novel orally active p53-MDM2 interaction inhibitors
    Miyazaki, Masaki
    Naito, Hiroyuki
    Sugimoto, Yuuichi
    Yoshida, Keisuke
    Kawato, Haruko
    Okayama, Tooru
    Shimizu, Hironari
    Miyazaki, Masaya
    Kitagawa, Mayumi
    Seki, Takahiko
    Fukutake, Setsuko
    Shiose, Yoshinobu
    Aonuma, Masashi
    Soga, Tsunehiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4319 - 4331
  • [5] Design and synthesis of new inhibitors of p53-MDM2 interaction with a chalcone scaffold
    Pereira, Daniela
    Lima, Raquel T.
    Palmeira, Andreia
    Seca, Hugo
    Soares, Joana
    Gomes, Sara
    Raimundo, Liliana
    Maciel, Claudia
    Pinto, Madalena
    Sousa, Emilia
    Helena Vasconcelos, M.
    Saraiva, Lucilia
    Cidade, Honorina
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 4150 - 4161
  • [6] Proteomimetic libraries: Design, synthesis, and evaluation of p53-MDM2 interaction inhibitors
    Lu, F
    Chi, SW
    Kim, DH
    Han, KH
    Kuntz, ID
    Guy, RK
    JOURNAL OF COMBINATORIAL CHEMISTRY, 2006, 8 (03): : 315 - 325
  • [7] Small-Molecule Inhibitors of the p53-MDM2 Interaction
    Vu, Binh T.
    Vassilev, Lyubomir
    SMALL-MOLECULE INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS, 2011, 348 : 151 - 172
  • [8] QSAR: Hydropathic analysis of inhibitors of the p53-mdm2 interaction
    Galatin, PS
    Abraham, DJ
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2001, 45 (03) : 169 - 175
  • [9] Patented small molecule inhibitors of p53-MDM2 interaction
    Deng, JX
    Dayam, R
    Neamati, N
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (02) : 165 - 188
  • [10] Pharmacophore model construction of p53-MDM2 binding inhibitors
    Sheng Rong
    Hu Chun-Qi
    Huang Wen-Hai
    Hu Yong-Zhou
    ACTA PHYSICO-CHIMICA SINICA, 2007, 23 (11) : 1815 - 1820